Imricor Commences VISABL-VT Trial

Contributed by: Business Wire

Logo

Images

Business Wire embedded0

Tags

Software

Other Health

General Health

Hardware

Technology

Medical Devices

Hospitals

Health Technology

Surgery

Clinical Trials

Cardiology

Biotechnology

Health

VISABL-VT Trial

More Like This

VISABL-AFL Procedure at ICPS (Photo: Business Wire)

Imricor’s VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris

PR Newswire associated0

Adagio Medical Announces Initiation and First Procedure in FULCRUM-VT Trial, Starting The Process For Bringing Ultra-Low Temperature Cryoablation for Ventricular Arrhythmias to US Market

PR Newswire associated0

Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers

MedLumics New CEO and Board Member Announces 10 Patients Treated in First in Man (FIM) Clinical Trial With the Real-Time Visually Guided AblaView PFA System

vMap is a non-invasive tool developed with AI that transforms standard 12-lead ECG data into 3D arrhythmia source maps in under a minute.

Vektor Medical Secures CE Mark for vMap, Bringing the Benefits of Non-Invasive Arrhythmia Mapping to Europe

PR Newswire associated0

Circulation Publishes 6-Month Outcomes from First-in-Human VCAS Trial of FieldForce™ Pulsed Field Ablation System: 82% Freedom from VT/VF Recurrence and 98% Reduction in Burden

Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial

PR Newswire associated0

Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study